Medical marijuana
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Notable studies
- 2016, Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.[2]
References
- ↑ Ryan, Duncan; Drysdale, Alison J.; Lafourcade, Carlos; Pertwee, Roger G.; Platt, Bettina (February 18, 2009), "Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels", The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29 (7): 2053–2063, doi:10.1523/JNEUROSCI.4212-08.2009, ISSN 1529-2401, PMID 19228959
- ↑ Jadoon, Khalid A.; Ratcliffe, Stuart H.; Barrett, David A.; Thomas, E. Louise; Stott, Colin; Bell, Jimmy D.; O’Sullivan, Saoirse E.; Tan, Garry D. (August 29, 2016), "Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study", Diabetes Care: American Diabetes Association, 39 (10): 1777–86, doi:10.2337/dc16-0650 Cite has empty unknown parameter:
|1=(help)
